Fluoxetine and Cilostazol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluoxetine (fluoxetine hydrochloride) and Cilostazol (cilostazol). Common drug interactions include rhinalgia among females and chorea among males.

The phase IV clinical study analyzes what interactions people have when they take Fluoxetine and Cilostazol. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.

What is Fluoxetine?

Fluoxetine has active ingredients of fluoxetine hydrochloride. It is often used in depression. eHealthMe is studying from 98,823 Fluoxetine users. Check the latest studies of Fluoxetine.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.



On Jul, 17, 2026

74 people who take Fluoxetine and Cilostazol together, and have interactions are studied.

Fluoxetine and Cilostazol drug interactions.

What are the common drug interactions of Fluoxetine and Cilostazol, by gender? *:

female:

  1. Rhinalgia (pain in the nose)
  2. Sensation of foreign body
  3. Tinnitus (a ringing in the ears)
  4. Blindness
  5. Burning sensation
  6. Chronic kidney disease
  7. Neck pain
  8. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  9. Postnasal drip
  10. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)

male:

  1. Chorea (abnormal involuntary movement disorder)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Emotional distress
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Muscular weakness (muscle weakness)
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Pain
  8. Rib fracture
  9. Vomiting
  10. Abdominal pain

What are the common drug interactions of Fluoxetine and Cilostazol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Renal failure (kidney dysfunction)
  6. Renal tubular necrosis (death of kidney tubules)
  7. Thrombophlebitis deep (deep swelling (inflammation) of a vein caused by a blood clot)

50-59:

  1. Balance disorder
  2. Chronic kidney disease
  3. Gait disturbance
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Multiple fractures
  6. Muscular weakness (muscle weakness)
  7. Osteomalacia (softening of the bones due to a lack of vitamin d)
  8. Renal failure (kidney dysfunction)
  9. Abasia (inability to walk)
  10. Adverse reaction

60+:

  1. Tardive dyskinesia (a disorder that involves involuntary movements)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Chorea (abnormal involuntary movement disorder)
  4. Excoriation (to tear or wear off the skin of)
  5. Fall
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Pain
  8. Rhinalgia (pain in the nose)
  9. Sensation of foreign body
  10. Tinnitus (a ringing in the ears)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 20 people, 27.03%
  2. High Blood Cholesterol: 15 people, 20.27%
  3. Pain: 10 people, 13.51%
  4. High Blood Pressure: 10 people, 13.51%
  5. Joint Pain: 9 people, 12.16%
  6. Stress And Anxiety: 8 people, 10.81%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 9.46%
  8. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 7 people, 9.46%
  9. Essential Hypertension (primary hypertension): 7 people, 9.46%
  10. Infection: 6 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Fluoxetine and Cilostazol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fluoxetine and Cilostazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fluoxetine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cilostazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluoxetine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cilostazol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluoxetine hydrochloride and cilostazol (the active ingredients of Fluoxetine and Cilostazol, respectively), and Fluoxetine and Cilostazol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: